Chinese officials and state media have criticized the United States House of Representatives for pushing at least 25 hawkish China-related bills in a “China week” ahead of the US presidential election in November. Among the bills, the BioSecure Act was passed by the US House of Representatives by 306 to 81 votes on Monday to make American drug companies stop doing business with five Chinese biotechnology companies until 2032.